Suppr超能文献

社区获得性菌血症后的静脉血栓栓塞:一项为期20年的丹麦队列研究。

Venous thromboembolism after community-acquired bacteraemia: a 20-year danish cohort study.

作者信息

Dalager-Pedersen Michael, Søgaard Mette, Schønheyder Henrik C, Thomsen Reimar W, Baron John A, Nielsen Henrik

机构信息

Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark ; Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.

Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.

出版信息

PLoS One. 2014 Jan 23;9(1):e86094. doi: 10.1371/journal.pone.0086094. eCollection 2014.

Abstract

BACKGROUND

Infections may increase the risk for venous thromboembolism (VTE), but little is known about VTE risk associated with community-acquired bacteraemia (CAB). We examined the risk for VTE within one year of CAB in comparison to that in matched controls.

METHODS

We conducted a population-based cohort study in North Denmark 1992-2011, using data from high-quality health-care databases. We included 4,213 adult CAB patients who had positive blood cultures drawn on the day of hospital admission, 20,084 matched hospitalised controls admitted for other acute medical illness, and 41,121 matched controls from the general population. We computed 0-90 and 91-365 day absolute risks for hospital-diagnosed VTE and used regression analyses with adjustment for confounding factors to compare the risk for VTE in bacteraemia patients and controls.

RESULTS

Among CAB patients, 1.1% experienced VTE within 90 days of admission and 0.5% during 91-365 days after admission. The adjusted 90-day odds ratio (OR) for VTE was 1.9 (95% CI 1.4-2.7) compared with hospitalised controls, and 23.4 (95% CI 12.9-42.6) compared with population controls. During 91-365 days after CAB admission, the VTE risk remained moderately increased (adjusted hazard ratio vs. hospitalised controls, 1.4; 95% CI 0.8-2.5, and vs. population controls, 1.9; 95% CI 1.0-3.3). Compared to hospitalised controls, the 90-day VTE risk increase was greater for Gram-positive infection (adjusted OR 2.5; 95% CI 1.6-4.1) than for Gram-negative infection (adjusted OR, 1.2; 95% CI 0.7-2.1), partly due to a high risk after Staphylococcus aureus infection (3.6%).

CONCLUSION

The risk for VTE is substantially increased within 90 days after community-acquired bacteraemia when compared to hospitalised controls and population controls. However, the absolute risk of VTE following CAB is low.

摘要

背景

感染可能会增加静脉血栓栓塞症(VTE)的风险,但对于社区获得性菌血症(CAB)相关的VTE风险却知之甚少。我们比较了CAB患者与匹配对照组在一年内发生VTE的风险。

方法

我们于1992年至2011年在丹麦北部开展了一项基于人群的队列研究,使用来自高质量医疗保健数据库的数据。我们纳入了4213例成年CAB患者,这些患者在入院当天血培养呈阳性,20084例因其他急性内科疾病入院的匹配住院对照,以及41121例来自普通人群的匹配对照。我们计算了医院诊断VTE的0至90天和91至365天绝对风险,并使用对混杂因素进行调整的回归分析来比较菌血症患者和对照发生VTE的风险。

结果

在CAB患者中,1.1%在入院后90天内发生VTE,0.5%在入院后91至365天内发生VTE。与住院对照相比,VTE的校正90天比值比(OR)为1.9(95%CI 1.4 - 2.7),与人群对照相比为23.4(95%CI 12.9 - 42.6)。在CAB入院后91至365天期间,VTE风险仍有适度增加(与住院对照相比,校正风险比为1.4;95%CI 0.8 - 2.5,与人群对照相比为1.9;95%CI 1.0 - 3.3)。与住院对照相比,革兰氏阳性菌感染的90天VTE风险增加幅度大于革兰氏阴性菌感染(校正OR 2.5;95%CI 1.6 - 4.1),部分原因是金黄色葡萄球菌感染后风险较高(3.6%)。

结论

与住院对照和人群对照相比,社区获得性菌血症后90天内VTE风险大幅增加。然而,CAB后VTE的绝对风险较低。

相似文献

1
Venous thromboembolism after community-acquired bacteraemia: a 20-year danish cohort study.
PLoS One. 2014 Jan 23;9(1):e86094. doi: 10.1371/journal.pone.0086094. eCollection 2014.
3
Acute infections and venous thromboembolism.
J Intern Med. 2012 Jun;271(6):608-18. doi: 10.1111/j.1365-2796.2011.02473.x. Epub 2011 Dec 8.
5
Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study.
Circulation. 2014 Apr 1;129(13):1387-96. doi: 10.1161/CIRCULATIONAHA.113.006699. Epub 2014 Feb 12.
6
Functional status and quality of life after community-acquired bacteraemia: a matched cohort study.
Clin Microbiol Infect. 2016 Jan;22(1):78.e1-78.e8. doi: 10.1016/j.cmi.2015.09.006. Epub 2015 Sep 15.
10
Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a case-control study.
Epidemiol Infect. 2006 Dec;134(6):1167-73. doi: 10.1017/S0950268806006327. Epub 2006 Apr 20.

引用本文的文献

2
: Infections, Animal Modeling, and Therapeutics.
Cells. 2023 Jan 3;12(1):199. doi: 10.3390/cells12010199.
3
Venous thromboembolism in critically ill patients with pneumonia in the pre-COVID-19 era: Data from a large public database.
Res Pract Thromb Haemost. 2022 Oct 9;6(7):e12816. doi: 10.1002/rth2.12816. eCollection 2022 Oct.
4
Role of von Willebrand factor in venous thromboembolic disease.
JVS Vasc Sci. 2021 Oct 7;3:17-29. doi: 10.1016/j.jvssci.2021.08.002. eCollection 2022.
5
Has Growth Phase Dependent Affinity for Fibrinogen and Resulting Fibrin Clot Elasticity.
Front Microbiol. 2021 Jun 16;12:649534. doi: 10.3389/fmicb.2021.649534. eCollection 2021.
7
Acute infection as a trigger for incident venous thromboembolism: Results from a population-based case-crossover study.
Res Pract Thromb Haemost. 2017 Dec 21;2(1):85-92. doi: 10.1002/rth2.12065. eCollection 2018 Jan.
8
Structure, Mechanics, and Instability of Fibrin Clot Infected with Staphylococcus epidermidis.
Biophys J. 2017 Nov 7;113(9):2100-2109. doi: 10.1016/j.bpj.2017.09.001.
9
Hospitalization with infection and incident venous thromboembolism: The ARIC study.
Thromb Res. 2017 Mar;151:74-78. doi: 10.1016/j.thromres.2017.01.008. Epub 2017 Jan 25.

本文引用的文献

1
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096.
4
The role of hypervirulent Staphylococcus aureus infections in the development of deep vein thrombosis.
Thromb Res. 2012 Sep;130(3):302-8. doi: 10.1016/j.thromres.2012.06.013. Epub 2012 Jul 6.
6
Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review.
Thromb Haemost. 2012 May;107(5):827-37. doi: 10.1160/TH11-09-0611. Epub 2012 Mar 22.
7
8
Acute infections and venous thromboembolism.
J Intern Med. 2012 Jun;271(6):608-18. doi: 10.1111/j.1365-2796.2011.02473.x. Epub 2011 Dec 8.
9
The Danish National Patient Register.
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3. doi: 10.1177/1403494811401482.
10
Existing data sources for clinical epidemiology: Aarhus University Prescription Database.
Clin Epidemiol. 2010 Dec 2;2:273-9. doi: 10.2147/CLEP.S13458.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验